Showing results (1-10 of 6,086) with videos related to
Sort By:
Pageof 609
Clinical Transplantation|September 20, 2022
mTORi-based immunosuppression reduces HCC recurrence at the expense of increased adverse side effects: A systematic review and meta-analysisGongming Zhang, Binwei Duan, Guangming LiClinical Transplantation|September 20, 2022
Utility of geriatric assessments in evaluation of older adults for kidney transplantationKellie H Campbell, Daniel J Ahn, Frances Enger, et al.Clinical Transplantation|September 21, 2022
Treatment of acquired transthyretin amyloidosis in domino liver transplantationKonstantinos I Tsamis, Dimitrios Mytilinaios, Michael Heneghan, et al.Clinical Transplantation|November 6, 2022
Increased severe primary graft dysfunction in left ventricular assist device patients following united network for organ sharing allocation changesAaron Guo, Kunal Kotkar, Brandon Jocher, et al.Clinical Transplantation|November 29, 2014
Elevated immune monitoring early after cardiac transplantation is associated with increased plaque progression by intravascular ultrasoundRichard Cheng, Babak Azarbal, Aaron Yung, et al.Clinical Transplantation|December 23, 2014
Skin cancer evaluation in transplant patients: a physician opinion survey with recommendationsAmanda Lloyd, Goran Klintmalm, Huanying Qin, et al.Clinical Transplantation|October 21, 2014
Middle hepatic vein allocation in adult right lobe living donor liver transplantationZhu Zhijun, Gao Wei, Wei Lin, et al.Clinical Transplantation|November 11, 2014
Impact of human albumin infusion on organ function in orthotopic liver transplantation--a retrospective matched-pair analysisChristian Ertmer, Tim-Gerald Kampmeier, Thomas Volkert, et al.Clinical Transplantation|November 11, 2014
Low gravity rotational culture and the integration of immunomodulatory stem cells reduce human islet allo-reactivityKhalid M Qureshi, Jou Lee, Michelle B Paget, et al.Clinical Transplantation|October 24, 2015
Filgrastim versus TBO-filgrastim to reduce the duration of neutropenia after autologous hematopoietic stem cell transplantation: TBO, or not TBO, that is the questionSteven Trifilio, Zheng Zhou, John Galvin, et al.Pageof 609